SOUTH SAN FRANCISCO, Calif., March 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that it will hold a conference call on Monday, March 8, 2010 to discuss the Company’s fourth quarter and fiscal year 2009 financial results and provide a corporate update. Ronald A. Martell, chief executive officer, Michael S. Perry, president and chief medical officer, and Greg Weaver, senior vice president and chief financial officer, will host the call beginning at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). A press release for the fourth quarter ended December 31, 2009, will be released before the market opens and prior to the conference call on March 8, 2010.
To participate in the live call by telephone, please dial 866-543-6403 (United States) or 617-213-8896 (International). The passcode for the conference call is 50673823. In addition, the live conference call is being Webcast and can be accessed on the “Events” page of the “News & Events” section of the Company’s Web site at http://www.poniard.com. A replay of the Webcast will be available on the Company’s Web site for 10 days.
About Poniard Pharmaceuticals
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.
SOURCE Poniard Pharmaceuticals, Inc. Back to top
RELATED LINKS http://www.poniard.com
